Filter
15
Featured
Language
Document type
No document type
8
Guidelines
6
Training Material
1
Countries / Regions
Western and Central Europe
2
Global
1
USA
1
Latin America and the Carribbean
1
Authors & Publishers
World Health Organization WHO
5
European AIDS Clinical Society (EACS)
2
and B.M. Ances
1
and D.V.Havlir
1
Clinical Care Options
1
Clinical Info HIV
1
Currier, J.S.
1
EMTCT Global Validation Advisory Committee, Global HIV, Hepatitis and Sexually Transmitted Infections Programmes
1
i-base
1
Organisation Mondiale de la Santé OMS
1
Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
1
Spudich, S.S.
1
World Health Organization WHO
1
World Health Organization (WHO)
1
Publication Years
Category
HIV & STI
7
Dermatology
2
Hepatitis
1
Chagas
1
Toolboxes
Co-Morbidities (except TB)
15
Treatment & Prevention
4
Antiretroviral Treatment ART
3
ART Drug Resistance
2
Clinical Aspects
2
Opportunistic Infections
2
Treatment Guidelines HIV
2
HIV and coinfection
2
Clinical Aspects, Treatment & Prevention
1
For Pregnant Women
1
Training, others
1
Gender Aspects
1
HIV and COVID-19
1
COVID-19
1
TB/COVID-19
1
Zoonoses
1
NTDs
1
Chagas
1
Women
1
Prevention of mother-to-child transmission (PMTCT)
1
Version 10.1_5 October 2020 These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website. The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ... more
Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care workers caring for patients with HIV infection
Topics in Antiviral Medicine Volume 25 Issue 2 May/June 2017
Clinical Guidance across the continuum of care Chapter 8_ARV Guidelines
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa. These guidelines update the recommendations that were first released i... more
Version 9.0 Octobre 2017
Slideset updated regularly to include the latest data and guidance on COVID-19 risk and management in special populations, including children and pregnant women, and persons with comorbidities.
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination... more
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi... more
Epidemiology Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or... more